Clinical Trial Update: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluated adding Tumor Treating Fields (TTFields) to radiosurgery for patients with 1-10 brain metastases from non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Tumor Treating Fields (tumor treating fields)

Snippet

Sponsor: NovoCure GmbH | Conditions: Brain Metastases From Non-small Cell Lung Cancer (NSCLC) | Phase 3 | Status: COMPLETED